Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In commemoration of World Cancer Day on 4 February 2016, CSM statisticians present a TiTE-CRM phase I trial design for testing a chemoradiotherapy intervention in oesophageal cancer.

Computed tomography image of a radiotherapy plan for oesophageal cancer (tumour shown in red), delivered using intensity modulated radiotherapy. The radiotherapy target area is shown in yellow. Image by Maria Hawkins